India's Ajanta Pharma Sept-Quarter Profit Falls
SEPT-QUARTER NET PROFIT 1.16 BILLION RUPEES VERSUS 1.25 BILLION RUPEES YEAR AGO
SEPT-QUARTER REVENUE FROM OPERATIONS 6.43 BILLION RUPEES VERSUS 5.44 BILLION RUPEES YEAR AGO